title: Targeting IL-12, the key cytokine driving Th1-mediated autoimmune diseases.
authors.affiliation: Roche Milano Ricerche, Milano, Italia. Luciano.Adorini@Roche.com
authors.forename: L
authors.initials: L
authors.lastname: Adorini
authors.forename: F
authors.initials: F
authors.lastname: Aloisi
authors.forename: F
authors.initials: F
authors.lastname: Galbiati
authors.forename: M K
authors.initials: MK
authors.lastname: Gately
authors.forename: S
authors.initials: S
authors.lastname: Gregori
authors.forename: G
authors.initials: G
authors.lastname: Penna
authors.forename: F
authors.initials: F
authors.lastname: Ria
authors.forename: S
authors.initials: S
authors.lastname: Smiroldo
authors.forename: S
authors.initials: S
authors.lastname: Trembleau
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology*; D006801:Humans; D018664:Interleukin-12 / Q000276:immunology* / Q000502:physiology; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology / Q000502:physiology
chemical_list: D018664:Interleukin-12